We next optimized an IHC assay using a commercially available anti-DLL3 mAb (Ventana, SP347 clone) to evaluate DLL3 expression in a panel of neuroblastoma PDX models (Fig. 2A–C). Here, DLL3 is linked to neuroblastoma.